Literature DB >> 33360745

USP14 negatively regulates RIG-I-mediated IL-6 and TNF-α production by inhibiting NF-κB activation.

Hongrui Li1, Jiazheng Quan2, Xibao Zhao2, Jing Ling3, Weilin Chen4.   

Abstract

Ubiquitin specific protease 14 (USP14) is a regulator of protein deubiquitination and proteasome activation, and has been implicated in negative regulation of type I IFN signaling pathway. However, the effect of USP14 on RNA virus-related inflammatory response has not been studied. Retinoic acid-inducible gene I (RIG-I) is the important pattern recognition receptor of the innate immunity to detect RNA viruses or intracellular Poly(I:C)-LMW. Here, we reported that USP14 knockdown increased pro-inflammatory cytokines production in macrophages upon VSV infection or intracellular Poly(I:C)-LMW stimulation. USP14-overexpressed HeLa cells exhibited a decrease in RIG-I-mediated IL-6 and TNF-α expression. IU1, USP14 inhibitor, significantly promotes pro-inflammatory cytokines production in VSV-infected mice in vivo. Furthermore, USP14 was also found to inhibit the RIG-I-triggered NF-κB activation by deubiquitinating K63-linked RIG-I. Thus, our results demonstrate that USP14 is a negative regulator of RIG-I-mediated inflammatory response.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; Inflammatory response; Macrophages; NF-κB; RIG-I

Year:  2020        PMID: 33360745     DOI: 10.1016/j.molimm.2020.12.022

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

1.  Blockade of USP14 potentiates type I interferon signaling and radiation-induced antitumor immunity via preventing IRF3 deubiquitination.

Authors:  Weijian Wu; Huiying Xu; Chenyang Liao; Youqiao Wang; Ruirui Wu; Jiaxin Wu; Wenlv Zheng; Yunzhi Li; Chaoying Jin; Yuxuan Zhao; Junmin Quan; Xin Yue; Xianzhang Bu
Journal:  Cell Oncol (Dordr)       Date:  2022-10-07       Impact factor: 7.051

2.  miR-451a targeting IL-6R activates JAK2/STAT3 pathway, thus regulates proliferation and apoptosis of multiple myeloma cells.

Authors:  Lingling Xu; Yuning Yao; Ting Lu; Libo Jiang
Journal:  J Musculoskelet Neuronal Interact       Date:  2022-06-01       Impact factor: 1.864

3.  Choreographing atomic motions of macromolecular machines in action: Towards dynamics-based drug discovery.

Authors:  Shitao Zou; Youdong Mao
Journal:  Clin Transl Med       Date:  2022-08

4.  USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer.

Authors:  Dongni Shi; Xianqiu Wu; Yunting Jian; Junye Wang; Chengmei Huang; Shuang Mo; Yue Li; Fengtian Li; Chao Zhang; Dongsheng Zhang; Huizhong Zhang; Huilin Huang; Xin Chen; Y Alan Wang; Chuyong Lin; Guozhen Liu; Libing Song; Wenting Liao
Journal:  Nat Commun       Date:  2022-09-26       Impact factor: 17.694

Review 5.  USP14: Structure, Function, and Target Inhibition.

Authors:  Feng Wang; Shuo Ning; Beiming Yu; Yanfeng Wang
Journal:  Front Pharmacol       Date:  2022-01-05       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.